SCHEMBL2813853

SCHEMBL2813853

COc1cccc(CCNc2nc3c4c(n2)N(Cc2ccccc2)CCC4NN3)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.42
BCHE P06276 2/20 0.42
ACHE P22303 2/20 0.42
PDE5A O76074 1/20 0.40
SLC6A12 P48065 1/20 0.37
LMNA P02545 2/20 0.36
KDM1A O60341 4/20 0.36
RCOR1 Q9UKL0 4/20 0.36
EHMT2 Q96KQ7 3/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 1/20 0.35
CTSG P08311 1/20 0.34
CMA1 P23946 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
IP6K1 Q92551 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813048 0.93 IP6K1 (0.40) KDM1ARCOR1EHMT2MEN1KMT2A
SCHEMBL2814443 0.86 RXFP1 (0.35) ACHEMAPT
SCHEMBL2814269 0.85 RXFP1 (0.36) BACE1ACHEMEN1KMT2AALDH1A1
SCHEMBL2811115 0.84 MAPT (0.40) KDM1ARCOR1EHMT2MAPTSIGMAR1
SCHEMBL2813941 0.84 ADORA3 (0.41) BACE1ACHEMEN1KMT2AKDM4E
SCHEMBL2809448 0.84 ACHE (0.47) BACE1BCHEACHEMEN1KMT2A
SCHEMBL2810273 0.84 ADORA3 (0.41) BACE1ACHEMEN1KMT2AKDM4E
SCHEMBL2816455 0.84 SIGMAR1 (0.34) KDM4EALDH1A1MAPTSIGMAR1
SCHEMBL2813035 0.83 MCHR1 (0.36) KDM1ARCOR1EHMT2MAPTSIGMAR1
SCHEMBL2811021 0.83 BCHE (0.40) BACE1BCHEACHEPDE5ASLC6A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343983-B2 Substituted pyrazolo-pyrimidine compounds ARQULE, INC. (US) 2013-01-01 US disclosed
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS ARQULE, INC. (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249110-A1 SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS DPYD, TYMP, TP53 BACE1 3588/4885BCHE 4134/4885ACHE 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.